authors
- Sands, BE
- Moss, AC
- Armuzzi, A
- Marshall, John Kenneth
- Lindsay, JO
- Sandborn, WJ
- Danese, S
- Tsilkos, K
- Lawendy, N
- Zhang, H
- Friedman, GS
- Chan, G
- Krichbaum, DW
- Su, C
Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2018
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Journal of Crohn's and Colitis Journal